Ceapro Inc. to Present at the H.C. Wainwright Global Investment Conference
EDMONTON, Alberta, May 23, 2022 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro” or the “Company”), a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, today announced that Gilles Gagnon, President and Chief Executive Officer, of Ceapro, will present at the H.C. Wainwright Global Investment Conference being held May 23-26, 2022 in Miami, FL and virtually.
In addition to the presentation, management will be available to participate in virtual one-on-one meetings with qualified members of the investor community who are registered to attend the conference. For more information, please visit the conference website.
A video webcast of the presentation will be accessible for viewing on-demand beginning on Tuesday, May 24, 2022 at 7:00 AM ET for those registered for the event and will be available on the Events page in the Investors section of the Company’s website (ceapro.com). A webcast replay will be archived for 90 days following the event.
About Ceapro Inc.
For more information contact: